Apellis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 12.22 M | $390.01 M | 10.00% | 9.86% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 11.89 M | $379.44 M | 0.00% | 9.60% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 11.80 M | $376.57 M | -24.19% | 9.52% |
| VANGUARD GROUP INC | 02/11/2025 | 10.05 M | $320.57 M | 2.35% | 8.11% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 6.48 M | $206.71 M | 4.61% | 5.23% |
| STATE STREET CORP | 02/14/2025 | 4.53 M | $144.40 M | 11.98% | 3.65% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 4.27 M | $136.41 M | -2.86% | 3.45% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 3.01 M | $95.95 M | 0.00% | 2.43% |
| SIREN, L.L.C. | 02/14/2025 | 2.82 M | $89.87 M | 29.95% | 2.27% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 2.76 M | $88.08 M | 51.58% | 2.23% |
| UBS GROUP AG | 02/14/2025 | 2.59 M | $82.54 M | 722.01% | 2.09% |
| FMR LLC | 02/13/2025 | 2.13 M | $67.89 M | -26.64% | 1.72% |
| BRAIDWELL LP | 02/14/2025 | 2.10 M | $66.97 M | -32.84% | 1.69% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.86 M | $59.24 M | 127.15% | 1.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.84 M | $58.70 M | 1.57% | 1.48% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 1.78 M | $56.75 M | 1.77% | 1.44% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 1.58 M | $50.33 M | 45.76% | 1.27% |
| ROYAL BANK OF CANADA | 02/14/2025 | 1.52 M | $48.47 M | 969.63% | 1.23% |
| 02/14/2025 | 1.43 M | $45.50 M | 100.00% | 1.15% | |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 1.39 M | $44.21 M | 266,361.54% | 1.12% |
| CIBC WORLD MARKETS CORP | 02/10/2025 | 1.29 M | $41.01 M | 100.00% | 1.04% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.27 M | $40.46 M | 100.00% | 1.02% |
| NORGES BANK | 02/12/2025 | 1.09 M | $34.66 M | 100.00% | 0.88% |
| TORONTO DOMINION BANK | 02/19/2025 | 997,053 | $31.82 M | 3,791.39% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 996,748 | $31.81 M | 4.22% | 0.80% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 882,801 | $28.17 M | 2.62% | 0.71% |
| NATIXIS | 02/13/2025 | 870,627 | $27.78 M | 100.00% | 0.70% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 859,200 | $27.42 M | 9.10% | 0.69% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 850,823 | $27.15 M | 432.76% | 0.69% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 793,187 | $25.31 M | 100.00% | 0.64% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 744,194 | $23.75 M | 100.00% | 0.60% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 666,800 | $21.28 M | 13.02% | 0.54% |
| INVESCO LTD. | 02/13/2025 | 603,656 | $19.26 M | -0.08% | 0.49% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 575,490 | $18.36 M | 643.66% | 0.46% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 562,269 | $17.94 M | 36.50% | 0.45% |
| CANDRIAM S.C.A. | 02/07/2025 | 539,602 | $17.22 M | -20.65% | 0.44% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 500,000 | $15.96 M | 100.00% | 0.40% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 491,107 | $15.67 M | 44.14% | 0.40% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 420,000 | $13.40 M | 100.00% | 0.34% |
| JPMORGAN CHASE & CO | 02/12/2025 | 411,549 | $13.13 M | -89.41% | 0.33% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 394,823 | $12.60 M | 286.78% | 0.32% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 360,000 | $11.49 M | 53.19% | 0.29% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 358,578 | $11.44 M | -5.25% | 0.29% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 347,854 | $11.10 M | 16.75% | 0.28% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 345,885 | $11.04 M | -57.54% | 0.28% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 345,000 | $11.01 M | 32.69% | 0.28% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 341,361 | $10.89 M | 603.68% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 334,416 | $10.67 M | -2.71% | 0.27% |
| AMUNDI | 02/07/2025 | 329,582 | $10.88 M | 10,967.23% | 0.27% |
| JANE STREET GROUP, LLC | 02/14/2025 | 305,000 | $9.73 M | 11.56% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apellis Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 364 institutional investors and hedge funds held shares of Apellis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Avoro Capital Advisors LLC: 12.22 M
EcoR1 Capital, LLC: 11.89 M
WELLINGTON MANAGEMENT GROUP LLP: 11.8 M
VANGUARD GROUP INC: 10.05 M
BlackRock Funding, Inc. /DE: 6.48 M
STATE STREET CORP: 4.53 M
102.25% of Apellis Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 129.95 M shares in the last 24 months. This purchase volume represents approximately $4.47 B in transactions.